# US 2026/0167781 A1 · Silicone hydrogels formed from monofunctional urea-based silicone monomers

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2026/0167781 A1
- Document ID: US20260167781A1
- Status: Published application
- Kind: A1
- Application number: 19/421,417
- Filed: 2025-12-16
- Published: 2026-06-18
- Earliest claimed: 2024-12-17
- Applicants: Bausch + Lomb Ireland Limited
- Inventors: Jamie Homnick; Yongxing Qiu
- Web page: https://patentgrep.com/patent/US20260167781A1

## CPC

- C08F 230/085: {the monomer being a polymerisable silane, e.g. (meth)acryloyloxy trialkoxy silanes or vinyl trialkoxysilanes}
- C08J 3/075: Macromolecular gels
- A61F 2/16: Intraocular lenses
- C08F 2/48: by ultraviolet or visible light
- C08F 2/50: with sensitising agents
- C08F 257/02: on to polymers of styrene or alkyl-substituted styrenes
- C08J 3/24: Crosslinking, e.g. vulcanising, of macromolecules (mechanical aspects B29C35/00; crosslinking agents C08K)
- C08K 5/101: of monocarboxylic acids
- C08K 5/20: Carboxylic acid amides
- C08L 43/00: Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and containing boron, silicon, phosphorus, selenium, tellurium or a metal; Compositions of derivatives of such polymers (of metal salts, e.g. phenolates, alcoholates, see the parent compounds)
- G02B 1/043: {Contact lenses}
- C08J 2383/08: containing silicon bound to organic groups containing atoms other than carbon, hydrogen, and oxygen
- C08J 2439/06: Homopolymers or copolymers of N-vinyl-pyrrolidones
- C08J 2477/00: Characterised by the use of polyamides obtained by reactions forming a carboxylic amide link in the main chain; Derivatives of such polymers
- C08F: MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08J: WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H (working, e.g. shaping, of plastics B29)
- A61F: FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS (dental prosthetics A61C)
- C08K: Use of inorganic or non-macromolecular organic substances as compounding ingredients (paints, inks, varnishes, dyes, polishes, adhesives C09)
- C08L: COMPOSITIONS OF MACROMOLECULAR COMPOUNDS (compositions based on polymerisable monomers C08F, C08G; artificial filaments or fibres D01F; textile treating compositions D06)
- G02B: OPTICAL ELEMENTS, SYSTEMS OR APPARATUS

## Abstract

An ophthalmic device which is a polymerization product of a monomeric mixture including (a) one or more monofunctional urea-based silicone monomers represented by a structure of Formula I: wherein each R1 is independently an alkyl group; R2 is an alkyl group or a trialkyl siloxy group, R3 is an alkylene group, R4 is hydrogen or methyl and n is an integer from 1 to 12, (b) one or more ophthalmic device-forming hydrophilic comonomers or polymers, and (c) one or more cross-linking agents. The ophthalmic device is optically clear.

## Claims

### Claim 1

An ophthalmic device which is a polymerization product of a monomeric mixture comprising:
(a) one or more monofunctional urea-based silicone monomers represented by a structure of Formula I:
wherein each R1 is independently an alkyl group; R2 is an alkyl group or a trialkyl siloxy group, R3 is an alkylene group, R4 is hydrogen or methyl and n is an integer from 1 to 12;
(b) one or more ophthalmic device-forming hydrophilic comonomers or polymers; and
(c) one or more cross-linking agents;
wherein the ophthalmic device is optically clear.

### Claim 2 (depends on 1)

The ophthalmic device according to claim 1, wherein in the one or more monofunctional urea-based silicone monomers, R1 and R2 are independently a C1 to C6 alkyl group; R3 is a C1 to C6 alkylene group; and n is from 1 to 6.

### Claim 3 (depends on 1)

The ophthalmic device according to claim 1, wherein in the one or more monofunctional urea-based silicone monomers, R1 and R2 are independently a C1 to C3 alkyl group; R3 is a C1 to C3 alkylene group; and n is from 1 to 3.

### Claim 4 (depends on 1)

The ophthalmic device according to claim 1, wherein in the one or more monofunctional urea-based silicone monomers, R1 is a C1 to C6 alkyl group; R2 is a tri C1 to C6 alkyl siloxy group, R3 is a C1 to C6 alkylene group; and n is from 1 to 6.

### Claim 5 (depends on 1)

The ophthalmic device according to claim 1, wherein in the one or more monofunctional urea-based silicone monomers, R1 is a C1 to C3 alkyl group; R2 is a tri C1 to C3 alkyl siloxy group, R3 is a C1 to C3 alkylene group; and n is from 1 to 3.

### Claim 6 (depends on 1)

The ophthalmic device according to claim 1, wherein the one or more ophthalmic device-forming hydrophilic comonomers or polymers are selected from the group consisting of an unsaturated carboxylic acid, an acrylamide, a vinyl lactam, a hydroxyl-containing-(meth)acrylate, a hydrophilic vinyl carbonate, a hydrophilic vinyl carbamate, a hydrophilic oxazolone, and a poly(alkene glycol) functionalized with polymerizable groups.

### Claim 7 (depends on 1)

The ophthalmic device according to claim 1, wherein the one or more ophthalmic device-forming hydrophilic comonomers are one or more of a hydrophilic (meth)acrylate comonomer and an acrylamide comonomer.

### Claim 8 (depends on 1)

The ophthalmic device according to claim 1, wherein the one or more ophthalmic device-forming hydrophilic comonomers are one or more of a 2-hydroxyethyl acrylate, 2-hydroxyethyl methacrylate and dimethylacrylamide.

### Claim 9 (depends on 1)

The ophthalmic device according to claim 1, wherein the monomeric mixture comprises:
about 10 wt. % to about 45 wt. %, based on the total weight of the monomeric mixture, of the monofunctional urea-based silicone monomers; and
about 10 wt. % to about 90 wt. %, based on the total weight of the monomeric mixture, of the one or more ophthalmic device-forming hydrophilic comonomers.

### Claim 10 (depends on 1)

The ophthalmic device according to claim 1, wherein the monomeric mixture further comprises a cyclic polyamide having a weight average molecular weight of at most 300,000 Daltons (Da).

### Claim 11 (depends on 1)

The ophthalmic device according to claim 1, wherein the monomeric mixture further comprises a polyvinylpyrrolidone having a weight average molecular weight of at most 300,000 Da.

### Claim 12 (depends on 1)

The ophthalmic device according to claim 1, wherein the monomeric mixture further comprises a polyvinylpyrrolidone having a weight average molecular weight of at most 100,000 Da.

### Claim 13 (depends on 1)

The ophthalmic device according to claim 1, wherein the monomeric mixture further comprises a polyvinylpyrrolidone having a weight average molecular weight of at most 60,000 Da.

### Claim 14 (depends on 11)

The ophthalmic device according to claim 11, wherein the monomeric mixture comprises about 0.1 wt. % to about 10 wt. %, based on the total weight of the monomeric mixture, of the polyvinylpyrrolidone.

### Claim 15 (depends on 9)

The ophthalmic device according to claim 9, wherein the monomeric mixture further comprises about 0.1 wt. % to about 10 wt. %, based on the total weight of the monomeric mixture, of a polyvinylpyrrolidone having a weight average molecular weight of at most 300,000 Da.

### Claim 16 (depends on 1)

The ophthalmic device according to claim 1, which is a silicone contact lens.

### Claim 17

A method for making an ophthalmic device, comprising:
(a) curing in a mold a polymerization product of a monomeric mixture comprising:
(i) one or more monofunctional urea-based silicone monomers represented by a structure of Formula I:
wherein each R1 is independently an alkyl group; R2 is an alkyl group or a trialkyl siloxy group, R3 is an alkylene group, R4 is hydrogen or methyl and n is an integer from 1 to 12;
(ii) one or more ophthalmic device-forming hydrophilic comonomers or polymers; and
(iii) one or more cross-linking agents; and
(b) dry releasing the polymerization product from the mold,
wherein the ophthalmic device is optically clear.

### Claim 18 (depends on 17)

The method according to claim 17, wherein in the one or more monofunctional urea-based silicone monomers, R1 is independently a C1 to C6 alkyl group; R2 is a C1 to C6 alkyl group or a tri C1 to C6 alkyl siloxy group; R3 is a C1 to C6 alkylene group; and n is from 1 to 6.

### Claim 19 (depends on 17)

The method according to claim 17, wherein the monomeric mixture further comprises a polyvinylpyrrolidone having a weight average molecular weight of at most 300,000 Daltons (Da).

### Claim 20 (depends on 17)

The method according to claim 17, wherein the monomeric mixture comprises:
about 10 wt. % to about 45 wt. %, based on the total weight of the monomeric mixture, of the monofunctional urea-based silicone monomers;
about 10 wt. % to about 90 wt. %, based on the total weight of the monomeric mixture, of the one or more ophthalmic device-forming hydrophilic comonomers; and
about 0.1 wt. % to about 10 wt. %, based on the total weight of the monomeric mixture, of a cyclic polyamide having a weight average molecular weight of at most 300,000 Da.
